For the year ending 2025-12-31, TELA made $80,275K in revenue. -$38,830K in net income. Net profit margin of -48.37%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 80,275 | |||
| Cost of revenue (excluding amortization of intangible assets) | 25,554 | |||
| Amortization of intangible assets | 380 | |||
| Gross profit | 54,341 | |||
| Sales and marketing | 63,182 | |||
| General and administrative | 15,694 | |||
| Research and development | 9,220 | |||
| Total operating expenses | 88,096 | |||
| Loss from operations | -33,755 | |||
| Interest expense | 5,245 | |||
| Loss on extinguishment of debt | -888 | |||
| Other income | 1,287 | |||
| Total other expense, net | -4,846 | |||
| Loss before income tax (expense) benefit | -38,601 | |||
| Income tax (expense) benefit | 230 | |||
| Net loss | -38,831 | |||
| Foreign currency translation adjustment | 1 | |||
| Comprehensive loss | -38,830 | |||
| Basic EPS | -0.83 | |||
| Diluted EPS | -0.83 | |||
| Basic Average Shares | 46,947,932 | |||
| Diluted Average Shares | 46,947,932 | |||
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)